Evidence map›Paper›PMID 32231697›Full record

ReviewInterventional neurology2020

Mandatory Neuroendovascular Evolution: Meeting the New Demands.

Mohammad El-Ghanem, Francisco E Gomez, Prateeka Koul, Rolla Nuoman, Justin G Santarelli, Krishna Amuluru, Chirag D Gandhi, Eric R Cohen, Philip Meyers, Fawaz Al-Mufti

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Interventional neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Mohammad El-GhanemDepartment of Neurology, University of Arizona, Tuscon, Arizona, USA.
Francisco E GomezDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Prateeka KoulDepartment of Internal Medicine, Stamford Hospital, Stamford, Connecticut, USA.
Rolla NuomanDepartment of Neurology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Justin G SantarelliDepartment of Neurosurgery, New York Medical College, Westchester Medical Center, Valhalla, New York, USA.
Krishna AmuluruUniversity of Pittsburgh Medical Center Hamot, Great Lakes Neurosurgery and Neurointervention, Erie, Pennsylvania, USA.
Chirag D GandhiDepartment of Neurosurgery, New York Medical College, Westchester Medical Center, Valhalla, New York, USA.
Eric R CohenDepartment of Neurology and Neurosurgery, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
Philip MeyersDepartment of Radiology, Columbia University Medical Center, New York, New York, USA.
Fawaz Al-MuftiDepartment of Neurosurgery, New York Medical College, Westchester Medical Center, Valhalla, New York, USA.
New York Medical College · USColumbia University Irving Medical Center · USJohnson University · USRutgers New Jersey Medical SchoolStamford Hospital · USUniversity of Arizona · USUniversity of Pennsylvania · USUniversity of Pittsburgh Medical Center · USWestchester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditionally, patients undergoing acute ischemic strokes were candidates for mechanical thrombectomy if they were within the 6-h window from onset of symptoms. This timeframe would exclude many patient populations, such as wake-up strokes. However, the most recent clinical trials, DAWN and DEFUSE3, have expanded the window of endovascular treatment for acute ischemic stroke patients to within 24 h from symptom onset. This expanded window increases the number of potential candidates for endovascular intervention for emergent large vessel occlusions and raises the question of how to efficiently screen and triage this increase of patients. SUMMARY: Abbreviated pre-hospital stroke scales can be used to guide EMS personnel in quickly deciding if a patient is undergoing a stroke. Telestroke networks connect remote hospitals to stroke specialists to improve the transportation time of the patient to a comprehensive stroke center for the appropriate level of care. Mobile stroke units, mobile interventional units, and helistroke reverse the traditional hub-and-spoke model by bringing imaging, tPA, and expertise to the patient. Smartphone applications and social media aid in educating patients and the public regarding acute and long-term stroke care. KEY MESSAGES: The DAWN and DEFUSE3 trials have expanded the treatment window for certain acute ischemic stroke patients with mechanical thrombectomy and subsequently have increased the number of potential candidates for endovascular intervention. This expansion brings patient screening and triaging to greater importance, as reducing the time from symptom onset to decision-to-treat and groin puncture can better stroke patient outcomes. Several strategies have been employed to address this issue by reducing the time of symptom onset to decision-to-treat time.

Indexed as

Emergent large vessel occlusionEndovascular treatmentMechanical thrombectomyPrehospital stroke scaleStrokeTelestroke

Identifiers

PMID32231697
PMCPMC7098306
OpenAlexW2905326791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.